Issue
SICOT-J
Volume 3, 2017
Special Issue: "Musculoskeletal tumors: Current approaches and controversies" Guest Editor: A. Kulidjian
Article Number 47
Number of page(s) 9
Section Wrist & Hand
DOI https://doi.org/10.1051/sicotj/2017001
Published online 28 June 2017
  1. Murray PM (2004) Soft tissue sarcoma of the upper extremity. Hand Clin 20(3), 325–333. [CrossRef] [EDP Sciences] [PubMed]
  2. Tamurian RM, Gutow AP. 2004. Amputations of the hand and upper extremity in the management of malignant tumors. Hand Clin 20(2), 213–220. [CrossRef] [EDP Sciences]
  3. Henderson M, Neumeister MW, Bueno Jr. RA (2014) Hand tumors: II. Benign and malignant bone tumors of the hand. Plast Reconstr Surg 133(6), 814e–821e. [CrossRef] [PubMed]
  4. Bray PW, Bell RS, Bowen CV, Davis A, O’Sullivan B (1997) Limb salvage surgery and adjuvant radiotherapy for soft tissue sarcomas of the forearm and hand. J Hand Surg Am 22(3), 495–503.
  5. Hueman MT, Thornton K, Herman JM, Ahuja N (2008) Management of extremity soft tissue sarcomas. Surg Clin North Am 88(3), 539–557. [PubMed]
  6. Wright EH, Gwilym S, Gibbons CL, Critchley P, Giele HP (2008) Functional and oncological outcomes after limb-salvage surgery for primary sarcomas of the upper limb. J Plast Reconstr Aesthet Surg 61(4), 382–387.
  7. Collin C, Hajdu SI, Godbold J, Friedrich C, Brennan MF (1987) Localized operable soft tissue sarcoma of the upper extremity. Presentation, management, and factors affecting local recurrence in 108 patients. Ann Surg 205(4), 331–339. [PubMed]
  8. Alamanda VK, Crosby SN, Archer KR, Song Y, Schwartz HS, Holt GE (2012) Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study. Eur J Surg Oncol 38(12), 1178–1183. [CrossRef] [PubMed]
  9. Kang S, Han I, Kim S, Lee YH, Kim MB, Kim HS (2014) Outcomes after flap reconstruction for extremity soft tissue sarcoma: a case-control study using propensity score analysis. Eur J Surg Oncol 40(9), 1101–1108. [CrossRef] [PubMed]
  10. Talbot SG, Athanasian EA, Cordeiro PG, Mehrara BJ (2004) Soft tissue reconstruction following tumor resection in the hand. Hand Clin 20(2), 181–202.
  11. Saint-Cyr M, Langstein HN (2006) Reconstruction of the hand and upper extremity after tumor resection. J Surg Oncol 94(6), 490–503.
  12. Creighton JJ Jr, Peimer CA, Mindell ER, Boone DC, Karakousis CP, Douglass HO (1985) Primary malignant tumors of the upper extremity: retrospective analysis of one hundred twenty-six cases. J Hand Surg Am 10(6 Pt 1), 805–814.
  13. Brennan MF, Casper ES, Harrison LB, Shiu MH, Gaynor J, Hajdu SI (1991) The role of multimodality therapy in soft-tissue sarcoma. Ann Surg 214(3), 328. [PubMed]
  14. Clark MA, Fisher C, Judson I, Thomas JM (2005) Soft-tissue sarcomas in adults. N Engl J Med 353(7), 701–711. [CrossRef] [PubMed]
  15. Puhaindran ME, Healey JH, Athanasian EA (2010) Single ray amputation for tumors of the hand. Clin Orthop Relat Res 468(5), 1390–1395. [CrossRef] [PubMed]
  16. Ferrone ML, Raut CP (2012) Modern surgical therapy: limb salvage and the role of amputation for extremity soft-tissue sarcomas. Surg Oncol Clin N Am 21(2), 201–213. [CrossRef] [PubMed]
  17. Muramatsu K, Ihara K, Doi K, Hashimoto T, Seto S, Taguchi T (2008) Primary reconstruction with digital ray transposition after resection of malignant tumor. Arch Orthop Trauma Surg 128(10), 1017–1021.
  18. O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P et al. (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359(9325), 2235–2241. [CrossRef] [PubMed]
  19. Cheng EY, Dusenbery KE, Winters MR, Thompson RC (1996) Soft tissue sarcomas: preoperative versus postoperative radiotherapy. J Surg Oncol 61(2), 90–99.
  20. DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ et al. (2003) Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 56(4), 1117–1127.
  21. Gortzak E, Azzarelli A, Buesa J, Bramwell VH, van Coevorden F, van Geel AN et al. (2001) A randomised phase II study on neo-adjuvant chemotherapy for “high-risk” adult soft-tissue sarcoma. Eur J Cancer 37(9), 1096–1103. [CrossRef] [PubMed]
  22. Lindner LH, Issels RD (2011) Hyperthermia in soft tissue sarcoma. Curr Treat Options Oncol 12, 1, 12–20. [CrossRef] [PubMed]
  23. Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC et al. (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11(6), 561–570.
  24. Daigeler A, Zmarsly I, Hirsch T, Goertz O, Steinau HU, Lehnhardt M, Harati K (2014) Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma. Br J Cancer 110(6), 1456–1464.
  25. Tos P, Artiaco S, Linari A, Battiston B (2009) Chondrosarcoma in the distal phalanx of index finger: clinical report and literature review. Chir Main 28(4), 265–269. [EDP Sciences]
  26. Patil S, de Silva MV, Crossan J, Reid R (2003) Chondrosarcoma of small bones of the hand. J Hand Surg Br 28(6), 602–608. [CrossRef] [PubMed]
  27. O’Connor MI, Bancroft LW (2004) Benign and malignant cartilage tumors of the hand. Hand Clin 20(3), 317–323. [CrossRef] [PubMed]
  28. Exner GU, Dumont CE, Malinin TI, von Hochstetter AR (2003) Recurrent aggressive chondrosarcoma of the middle phalanx of the index finger: excision and reconstruction with an osteocartilaginous allograft. Arch Orthop Trauma Surg 123(8), 425–428.
  29. Bovee JV, van der Heul RO, Taminiau AH, Hogendoorn PC (1999) Chondrosarcoma of the phalanx: a locally aggressive lesion with minimal metastatic potential: a report of 35 cases and a review of the literature. Cancer 86(9), 1724–1732. [CrossRef] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.